The Use of Mebeverine in Irritable Bowel Syndrome. A Position Paper of the Romanian Society of Neurogastroenterology based on Evidence

Authors

  • Dan L. Dumitrascu 2nd Medical Department, Iuliu Hatieganu University of Medicine and Pharmacy Cluj- Napoca, Romania
  • Alexandra Chira 2nd Medical Department, Iuliu Hatieganu University of Medicine and Pharmacy Cluj- Napoca, Romania
  • Simona Bataga University of Medicine and Pharmacy, Tg-Mures, Romania
  • Mircea Diculescu Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Bucharest, Romania
  • Vasile Drug Gr. T. Popa University of Medicine and Pharmacy, Institute of Gastroenterology and Hepatology, Iasi, Romania
  • Cristian Gheorghe Center of Gastroenterology and Hepatology, Fundeni Clinical Institute, Bucharest, Romania
  • Adrian Goldis Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy, Timisoara, Romania
  • Laurentiu Nedelcu Department of Internal Medicine, Transilvania University Brasov, Romania
  • Paul J. Porr Lucian Blaga University, Sibiu, Romania
  • Ioan Sporea Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy, Timisoara, Romania

DOI:

https://doi.org/10.15403/jgld.2014.1121.234.mibs

Keywords:

.

Abstract

.

Downloads

Published

2014-12-01

How to Cite

1.
Dumitrascu DL, Chira A, Bataga S, Diculescu M, Drug V, Gheorghe C, Goldis A, Nedelcu L, Porr PJ, Sporea I. The Use of Mebeverine in Irritable Bowel Syndrome. A Position Paper of the Romanian Society of Neurogastroenterology based on Evidence. JGLD [Internet]. 2014 Dec. 1 [cited 2026 Mar. 13];23(4):431-5. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/1365

Issue

Vol. 23 No. 4: December 2014

Section

Romanian SNG corner